Literature DB >> 1521917

Effects of areca nut on growth, differentiation and formation of DNA damage in cultured human buccal epithelial cells.

K Sundqvist1, R C Grafström.   

Abstract

Because the high incidence of oral cancers in South-East Asia is causally linked to the common habit of betel quid chewing, the effects of an aqueous extract of areca nut, one of the main ingredients of the quid, on growth, differentiation, morphology and DNA damage were studied in cultured human buccal epithelial cells. An acute exposure (3 hr) of the cells to the extract altered their morphology and induced ridges in the plasma membrane, with indications of internalization of extract particles. Such exposure also caused formation of DNA single-strand breaks which accumulated during post-treatment culture, indicating continuous exposure to residual particles and/or the possibility of inhibited DNA repair. The extract accelerated terminal differentiation of the cells, measured as involucrin expression at relatively non-toxic levels. The extract caused similar loss of colony-forming efficiency in normal cells and in a buccal carcinoma cell line (SqCC/YI) which was defective in its ability to undergo differentiation, indicating that extract toxicity could occur independently from this response. Finally, the genotoxicity of the salivary areca-nut-specific carcinogen 3-(N-nitrosomethyl-amino)propionaldehyde, was demonstrated by the formation of DNA protein cross-links and DNA single-strand breaks in normal buccal epithelial cells. These findings in vitro suggest that betel quid carcinogenesis in the human oral cavity may involve cytopathic alterations of normal cell morphology, growth and differentiation, as well as formation of DNA damage by areca-nut-related agents extracted or formed in saliva.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521917     DOI: 10.1002/ijc.2910520225

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus.

Authors:  Gwo-Hwa Wan; Shu-Chen Tsai; Daniel Tsun-Yee Chiu
Journal:  Endocrine       Date:  2002-11       Impact factor: 3.633

2.  Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma.

Authors:  Jeff Yi-Fu Chen; Chih-Chang Hung; Kai-Lieh Huang; Yi-Ting Chen; Shyun-Yeu Liu; Wei-Fan Chiang; Hau-Ren Chen; Ching-Yu Yen; Yu-Jen Wu; Jenq-Yuh Ko; Yuh-Shan Jou
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 3.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling.

Authors:  Mei-Chi Chang; Chiu-Po Chan; Yi-Jane Chen; Hsiang-Chi Hsien; Ya-Ching Chang; Sin-Yuet Yeung; Po-Yuan Jeng; Ru-Hsiu Cheng; Liang-Jiunn Hahn; Jiiang-Huei Jeng
Journal:  Oncotarget       Date:  2016-03-29

5.  Arecanut as an emerging etiology of oral cancers in India.

Authors:  Gunjan Shah; Pankaj Chaturvedi; Sagar Vaishampayan
Journal:  Indian J Med Paediatr Oncol       Date:  2012-04

6.  Prevalence and Risk Factors for Oral Potentially Malignant Disorders in Indian Population.

Authors:  Sandeep Kumar; Nitai Debnath; Mohammed B Ismail; Arunoday Kumar; Amit Kumar; Bhumika K Badiyani; Pavan K Dubey; Laxmi V Sukhtankar
Journal:  Adv Prev Med       Date:  2015-08-11

7.  Areca nut components affect COX-2, cyclin B1/cdc25C and keratin expression, PGE2 production in keratinocyte is related to reactive oxygen species, CYP1A1, Src, EGFR and Ras signaling.

Authors:  Mei-Chi Chang; Yi-Jane Chen; Hsiao-Hua Chang; Chiu-Po Chan; Chien-Yang Yeh; Yin-Lin Wang; Ru-Hsiu Cheng; Liang-Jiunn Hahn; Jiiang-Huei Jeng
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.